The impact of COVID-19 infection on hip fractures 30-day mortality

Ahmed Fadulelmola1, Rob Gregory1, Gavin Gordon1

  • 1University Hospital of North Durham, County Durham & Darlington NHSF, Newcastle upon Tyne, UK.

PubMed

Insights

COVID-19 infection significantly increases 30-day mortality for hip fracture patients. Early COVID-19 testing and chest X-rays are crucial for managing these high-risk surgical cases and informing prognosis.

Area of Science:

  • Geriatric Medicine
  • Infectious Diseases
  • Orthopedic Surgery

Background:

  • The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses a significant threat, particularly to the elderly and individuals with comorbidities.
  • Hip fractures are common in the elderly, requiring hospitalization and increasing vulnerability to COVID-19 infection.

Purpose of the Study:

  • To investigate the impact of COVID-19 infection on 30-day mortality rates in patients with hip fractures.
  • To analyze the relationship between COVID-19 status, time to surgery, and mortality outcomes in hip fracture patients.

Main Methods:

  • Retrospective review of 75 adult hip fracture patients admitted between March and April 2020.
  • Primary outcome: 30-day mortality in COVID-19 positive versus negative patients.

Main Results:

  • COVID-19 infection rate was 26.7% (20 patients).
  • 30-day mortality was significantly higher in COVID-19 positive patients (50%) compared to negative patients (7.3%).
  • Hypoxia was the cause of death in all COVID-19 positive fatalities; 70% had radiological signs of viral pneumonitis.

Conclusions:

  • Hip fractures combined with COVID-19 infection are associated with a high 30-day mortality rate.
  • Prompt COVID-19 testing and chest X-rays are essential for early risk assessment and surgical planning in hip fracture patients.
  • Accurate prognosis and patient/family counseling are vital when managing hip fracture patients with COVID-19.
Abstract